Turn one change into a reviewer-ready closure packet.
The Regulatory Change Integrity Review — the ClinicOps flagship engagement — starts with one approved or authoritative change and a defined evidence population. ClinicOps structures the source register, maps affected surfaces, reconciles available evidence, exposes unresolved questions and prepares the packet for accountable human review.
What the pack contains
Know what controls the change
Approved or authoritative source, version/date, provenance pointer, declared scope, assumptions and exclusions.
See where the change should be checked
Declared systems, records, documents, sites, vendors or people with observed evidence state, owner and expected closure evidence.
Route uncertainty instead of hiding it
Missing evidence, ownership ambiguity, conflicting versions and interpretation questions are kept explicit and assigned to the right owner.
Prepare accountable review
Signals are separated from judgments, closure references are retained, and unresolved items remain visible until the accountable owner decides or routes them.
Avoid unnecessary platform dependence
Where practical, delivery uses portable human- and machine-readable formats such as HTML, JSON, CSV and Markdown rather than locking the evidence into one interface.
Keep the evidence population controlled
The pack is tied to the declared change event and evidence population so later additions or changes can be identified rather than silently mixed into the original review.
Where it fits
Primary market: medical-device RA/QA
Controlled regulatory sources reconciled against EUDAMED and UDI/master data, IFUs and labels, SS(C)P masters and translations, certificates, declarations and downstream handoffs — the surfaces described under use cases.
Partner channel: ARs & specialist consultancies
The same review applied across a managed manufacturer portfolio: triage records, detect missing evidence, produce portable evidence packets. The partner's qualified team makes the regulatory judgement.
The method is domain-portable (trials, quality systems, laboratory and content workflows have been modelled internally), but ClinicOps deliberately sells it where the evidence is: EU MedTech regulatory data.
The operating structure stays consistent while the source requirements, review depth and accountable decision owner remain specific to each workflow.
Minimum starting point
If the scope is not yet clear, ClinicOps defines the evidence population first so the review starts from a controlled baseline.
Built for controlled change work
When an approved source changes, the operational challenge is proving what downstream records, systems, documents and owners were affected—and closing the gaps without losing traceability. The Regulatory Change Integrity Review gives teams a clear operating structure for that work.
Clear operational output
You receive a versioned source register, change-surface matrix, unresolved queue and closure packet that can be reviewed, handed over and used to drive the next accountable action.
Repeatable operating structure
The same core structure can be reused for future change events while the source set, review depth and decision owner stay specific to the workflow in front of you.
Start with evidence, not a sales deck
Use the free Change Surface Mapper to structure one live change. If the map reveals unresolved owners, missing evidence, conflicting versions or a meaningful reconciliation queue, carry that context into a ClinicOps scope brief.